23andMe Files for Bankruptcy, CEO Steps Down Amid Data Security Concerns

U.S. stock futures have dipped as investors brace for upcoming tariffs announced by the Trump administration, with uncertainty continuing to overshadow market optimism. Despite a recent rally in Wall Street's main indexes, consumer confidence has plummeted to its lowest level in over four years, raising concerns about broader economic implications. Meanwhile, genetic testing company 23andMe has filed for bankruptcy, prompting New York Attorney General Leticia James to advise customers to delete their data due to potential risks associated with the sale of customer genetic profiles. The company's CEO has stepped down as it seeks to maximize the value of its assets amid ongoing data security concerns following a major hack that exposed personal information of millions. This situation has left many customers questioning the safety of their genetic data in light of the company's financial instability. Additionally, Trump has threatened tariffs on countries buying Venezuelan oil, further contributing to market anxiety.